References
- Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention 2008. Available from: www.ginasthma.com (accessed 1 December, 2014).
- Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014, Available from: http://www.goldcopd.org (accessed 16 November, 2014).
- Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011; 105:930–938.
- Price D, Bosnic-Anticevich S, Briggs A, et al. Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med 2013; 107:37–46.
- Jung E, Pickard AS, Salmon JW, et al. Medication adherence and persistence in the last year of life in COPD patients. Respir Med 2009; 103:525–534.
- Mäkelä MJ, Backer V, Hedegaard M, Larsson K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med 2013; 107:1481–490.
- Gupta VK, Bahia JS, Maheshwari A, et al. To study the attitudes, beliefs and perceptions regarding the use of inhalers among patients of obstructive pulmonary diseases and in the general population in Punjab. J Clin Diagn Res 2011; 5:434–439.
- Chorão P, Pereira AM, Fonseca JA. Inhaler devices in asthma and COPD—An assessment of inhaler technique and patient preferences. Respir Med 2014; 108:968–975.
- De Blaquiere P, Christensen DB, Carter WB, Martin TR. Use and misuse of metered-dose inhalers by patients with chronic lung disease. A controlled, randomized trial of two instruction methods. Am Rev Respir Dis 1989; 140:910–916.
- Welch MJ, Nelson HS, Shapiro G, et al. Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers. J Aerosol Med 2004; 17:129–139.
- Taffet GE, Donohue JF, Altman PR. Considerations for managing chronic obstructive pulmonary disease in the elderly. Clin Interv Aging 2014; 9:23–30.
- Chrystyn H, Nierderlaender C. The Genuair inhaler. A novel, multidose dry powder inhaler. Int J Clin Pract 2012; 66:309–317.
- Magnussen H, Watz H, Zimmermann I, et al. Peak inspiratory flow through the Genuair® inhaler in patients with moderate or severe COPD. Respir Med 2009; 103:1832–1837.
- Newman SP, Sutton DJ, Segarra R, et al. Lung deposition of aclidinium bromide from Genuair®, a multidose dry powder inhaler. Respiration 2009; 78:322–328.
- van der Palen J, Ginko T, Kroker A, et al. Preference, satisfaction and errors with two dry powder inhalers in patients with COPD. Expert Opin Drug Deliv 2013; 10:1023–1031.
- Hass C, Engdahl K, Albert W, et al. Patient preferences and perceived ease of use in inhaler features: Genuair® vs other inhalers. Poster presented at the American College of Chest Physicians Annual Congress, Vancouver, BC, Canada, 30 October–4 November, 2010.
- Gálffy G, Mezei G, Németh G, et al. Inhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicentre studies in asthma and COPD. Drugs R D 2013; 13:215–222.